Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD

It is known that patients with chronic kidney disease are at increased risk of death from cardiovascular disease. This review nicely addresses the identification and management of lipid levels in patients with CKD and discusses the controversies regarding testing and treatment of lipid levels in this population. : Metformin in Patients With Type 2 Diabetes and Kidney Disease: A Systematic Review Asymmetrical Dimethylarginine Is Associated with Renal and Cardiovascular Outcomes and All-cause Mortality in Renal Transplant Recipients Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.
Source: Nephrology Now - Category: Urology & Nephrology Authors: Tags: Chronic Kidney Disease Clinical Nephrology Source Type: research